Ambit RD has filed a notice of an exempt offering of securities to raise $1,500,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Ambit RD is raising $1,500,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Robert Sederman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Ambit RD
Ambit is a solutions company. Because that’s exactly what we deliver. We know how complex biopharma problems can be so we meet them with best-in-class talent, cutting edge data & analytics technology, and the expertise earned through decades of work in rare and specialty diseases. With an interconnected approach from analysis, to insight, to activation, we deliver products and services that change the trajectory of our clients businesses. So give us your biggest challenges. The solution is here.
To learn more about Ambit RD, visit http://www.ambitinc.com/
Contact:
Robert Sederman, Chief Executive Officer
609-335-2681
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.